Jump to content

Pages with the fewest revisions

Showing below up to 50 results in range #651 to #700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Problem:Glaucoma (2 revisions)
  2. Fexofenadine (2 revisions)
  3. Effect:Component controllability (2 revisions)
  4. Problem:VTE prevention or treatment (2 revisions)
  5. Effect:Increased music appreciation (2 revisions)
  6. Problem:Chronic kidney disease in type 2 diabetes (2 revisions)
  7. Cholecalciferol (2 revisions)
  8. Effect:Pattern recognition enhancement (2 revisions)
  9. Effect:Insomnia (2 revisions)
  10. Turmeric (2 revisions)
  11. Simvastatin (2 revisions)
  12. Effect:Atemporality (2 revisions)
  13. Effect:Itchiness (2 revisions)
  14. Amoxicillin (2 revisions)
  15. Effect:Coincidence intensification (2 revisions)
  16. Effect:Pain relief (2 revisions)
  17. Phenotype:NUDT15 intermediate metabolizer (2 revisions)
  18. Effect:Magnification (2 revisions)
  19. Phenotype:UGT1A1 poor metabolizer (2 revisions)
  20. Cyanocobalamin (2 revisions)
  21. Effect:Hallucinations (2 revisions)
  22. Problem:Impulsivity (2 revisions)
  23. Ipratropium (2 revisions)
  24. Effect:Optical sliding (2 revisions)
  25. Problem:Hoarding Disorder (2 revisions)
  26. Mometasone (2 revisions)
  27. Effect:Serious cardiac event (2 revisions)
  28. Problem:Cyclothymic Disorder (2 revisions)
  29. Effect:Peripheral vasculopathy (2 revisions)
  30. Problem:Hangover (2 revisions)
  31. Ketoconazole (2 revisions)
  32. Effect:Auditory distortion (2 revisions)
  33. Problem:Psoriasis (2 revisions)
  34. Effect:Environmental orbism (2 revisions)
  35. Problem:Dependent Personality Disorder (2 revisions)
  36. Sodium Bicarbonate (2 revisions)
  37. Effect:Brightness alteration (2 revisions)
  38. Problem:Fatigue (2 revisions)
  39. Effect:Sociability depression (2 revisions)
  40. Problem:Rosacea (2 revisions)
  41. Adalimumab (2 revisions)
  42. Effect:Orthostatic hypotension (2 revisions)
  43. Problem:Anxiety (2 revisions)
  44. Pravastatin (2 revisions)
  45. Effect:Immersion intensification (2 revisions)
  46. Problem:Parkinson disease (2 revisions)
  47. Mupirocin (2 revisions)
  48. Effect:Existential self-realization (2 revisions)
  49. Problem:MASH with stage 2-3 fibrosis (2 revisions)
  50. Insulin Glargine (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)